Neurocrine Biosciences, Inc. News
All the news that matters to Neurocrine Biosciences, Inc.
Neurocrine (NBIX) Q3 2026 Earnings Call Transcript
www.nasdaq.com | 04:44 Tue 3 Nov 2026
Read More →
Neurocrine Sets Benchmark For Measuring Health Improvements In Tardive Dyskinesia Patients
www.nasdaq.com | 14:14 Mon 26 Oct 2026
Read More →
Where Will Neurocrine Biosciences Be in 5 Years?
www.nasdaq.com | 11:07 Sun 25 Oct 2026
Read More →
Neurocrine Presents Real-World Data Mapping Evolving Impact Of Congenital Adrenal Hyperplasia
www.nasdaq.com | 14:11 Fri 16 Oct 2026
Read More →
NBIX October 2027 Options Begin Trading
www.nasdaq.com | 15:46 Wed 14 Oct 2026
Read More →
Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference
finance.yahoo.com | 13:30 Wed 30 Sept 2026
Read More →